RCS - Bellevue Asset Mgmt - Doceo - Bellevue Healthcare Trust update

Bellevue AGAnnouncement

14/02/2023 10:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230214:nRSN8736Pa&default-theme=true

RNS Number : 8736P  Bellevue Asset Management  14 February 2023

 

Bellevue Healthcare Trust have launched new video content with doceo.

Bellevue Healthcare Trust intends to invest in a concentrated portfolio of
listed or quoted equities in the global healthcare industry. The investable
universe for the fund is the global healthcare industry including companies
within industries such as pharmaceuticals, biotechnology, medical devices and
equipment, healthcare insurers and facility operators, information technology
(where the product or service supports, supplies or services the delivery of
healthcare), drug retail, consumer healthcare and distribution.

In this latest update, Paul Major, gives a detailed account of the portfolio
and his outlook for healthcare in the medium to long term. Paul focusses on a
number of key themes in the portfolio, and why he believes they will be
crucial to a shifting healthcare ecosystem in the years to come:

 

 

 

For further information on doceo please visit www.doceo.tv
(https://www.doceo.tv/)  or contact the team on info@doceo.tv

 

 

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEANALFALDEEA